Jinchun Wu

2.2k total citations · 1 hit paper
14 papers, 1.6k citations indexed

About

Jinchun Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Jinchun Wu has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Jinchun Wu's work include Ferroptosis and cancer prognosis (5 papers), Sarcoma Diagnosis and Treatment (3 papers) and RNA modifications and cancer (3 papers). Jinchun Wu is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Sarcoma Diagnosis and Treatment (3 papers) and RNA modifications and cancer (3 papers). Jinchun Wu collaborates with scholars based in China, United States and Canada. Jinchun Wu's co-authors include Yanhua Mou, Chaojun Duan, Bin Li, Chunfang Zhang, Jun Wang, Dan He, Omar Abdihamid, Yao Zhang, Bin Li and Jun Liang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Hematology & Oncology.

In The Last Decade

Jinchun Wu

13 papers receiving 1.5k citations

Hit Papers

Ferroptosis, a new form of cell death: opportunities and ... 2019 2026 2021 2023 2019 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinchun Wu China 7 1.1k 1.0k 829 175 101 14 1.6k
Deguang Liang United States 5 1.1k 1.0× 1.0k 1.0× 865 1.0× 176 1.0× 177 1.8× 6 1.7k
Corinne Godin France 14 1.1k 1.0× 1.1k 1.1× 929 1.1× 321 1.8× 75 0.7× 22 1.7k
Tal Hirschhorn United States 10 722 0.7× 781 0.8× 506 0.6× 118 0.7× 87 0.9× 15 1.3k
Christophe Louandre France 15 1.1k 1.0× 1.1k 1.1× 954 1.2× 304 1.7× 109 1.1× 29 1.8k
Amber D. Horbath United States 7 776 0.7× 806 0.8× 566 0.7× 149 0.9× 120 1.2× 8 1.3k
Daniel J. Fridman Canada 5 869 0.8× 901 0.9× 651 0.8× 142 0.8× 90 0.9× 9 1.3k
Shidai Jin China 20 779 0.7× 1.2k 1.2× 933 1.1× 328 1.9× 99 1.0× 42 1.7k

Countries citing papers authored by Jinchun Wu

Since Specialization
Citations

This map shows the geographic impact of Jinchun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinchun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinchun Wu more than expected).

Fields of papers citing papers by Jinchun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinchun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinchun Wu. The network helps show where Jinchun Wu may publish in the future.

Co-authorship network of co-authors of Jinchun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jinchun Wu. A scholar is included among the top collaborators of Jinchun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinchun Wu. Jinchun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Liu, Xiaoqian, Yuting Bai, Xiaoling Su, et al.. (2024). Hypoxia and ferroptosis. Cellular Signalling. 122. 111328–111328. 16 indexed citations
2.
Yi, Xiaoping, Gaofeng Zhou, Yan Fu, et al.. (2023). CT-based assessment of sarcopenia for differentiating wild-type from mutant-type gastrointestinal stromal tumor. Scientific Reports. 13(1). 3216–3216. 1 indexed citations
3.
Wu, Jinchun, et al.. (2022). Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma. Disease Markers. 2022. 1–13. 4 indexed citations
4.
Wu, Jinchun, Haiyan Zhou, Xiaoping Yi, et al.. (2021). Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs. Cancer Management and Research. Volume 13. 297–306. 2 indexed citations
5.
6.
Wu, Jinchun, Yongbin Hu, Omar Abdihamid, et al.. (2021). Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy. Frontiers in Oncology. 11. 684865–684865. 6 indexed citations
8.
Lai, Renchun, Abbas E. Abbas, Bernard J. Park, et al.. (2021). Learning curve of robotic portal lobectomy for pulmonary neoplasms: A prospective observational study. Thoracic Cancer. 12(9). 1431–1440. 14 indexed citations
9.
Mou, Yanhua, Yao Zhang, Jinchun Wu, et al.. (2020). The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 788–788. 17 indexed citations
10.
Mou, Yanhua, Jun Wang, Jinchun Wu, et al.. (2019). Ferroptosis, a new form of cell death: opportunities and challenges in cancer. Journal of Hematology & Oncology. 12(1). 34–34. 1393 indexed citations breakdown →
11.
Wu, Jinchun, et al.. (2018). Outcome Predictors of the Transforaminal Endoscopic Spine System Technique for Single-level Lumbar Disk Herniation. Journal of Neurological Surgery Part A Central European Neurosurgery. 79(4). 285–290. 7 indexed citations
12.
Liu, Zhaohui, et al.. (2012). [The correlation analysis between glucose level and its variability and prognosis in traumatic patients].. PubMed. 24(11). 643–6. 1 indexed citations
13.
Wu, Jinchun, et al.. (2011). Key pathways involved in prostate cancer based on gene set enrichment analysis and meta analysis. Genetics and Molecular Research. 10(4). 3856–3887. 12 indexed citations
14.
Jalal, Shadia I., Sumeet Bhatia, Lawrence H. Einhorn, et al.. (2008). Paclitaxel (P) plus bevacizumab (B) in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): A safety, feasibility and efficacy trial from the Hoosier Oncology Group. Journal of Clinical Oncology. 26(15_suppl). 19013–19013. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026